Wound care compositions comprising borate (B
Glass-based angiogenic particles of a biocompatible material which comprises 40 to about 80 wt% borate (B 2 O 3 ) intermixed into a carrier which is an ointment, cream, or surgical glue.
1. Glass-based particles of a biocompatible material intermixed into a carrier for angiogenesis in wound-care management,
wherein the glass-based particles comprise from 40 to about 80 wt % borate (B 2 O 3 );
wherein the carrier is a biocompatible ointment or cream or a surgical glue for closing a wound; and
wherein the glass-based particles are angiogenic.
2. The glass-based particles intermixed into a carrier of claim 1 , wherein the glass-based particles comprise one or more alkali oxides selected from the group consisting of Li 2 O, Na 2 O, K 2 O, and Rb 2 O, and one or more alkaline earth oxides selected from the group consisting of MgO, SrO, BaO, and CaO.
3. The glass-based particles intermixed into a carrier of claim 1 , wherein the glass-based particles comprise from about 50 to about 80 wt % B 2 O 3 .
4. The glass-based particles intermixed into a carrier of claim 1 , wherein the glass-based particles comprise from about 5 to about 20 wt % of one or more alkali oxides selected from the group consisting of Li 2 O, Na 2 O, K 2 O, and Rb 2 O, and from about 5 to about 40 wt % of one or more alkaline earth oxides selected from the group consisting of MgO, SrO, BaO, and CaO.
5. The glass-based particles intermixed into a carrier of claim 1 wherein the carrier is the biocompatible ointment or cream.
6. The glass-based particles intermixed into a carrier of claim 5 wherein the glass-based particles further comprise one or more trace elements selected from the group consisting of Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn in a concentration between about 0.05 and 10 wt % per trace element chemically dissolved in glass.
7. The glass-based particles intermixed into a carrier of claim 5 wherein the glass-based particles further comprise Cu in a concentration between about 0.05 and 10 wt % chemically dissolved in the glass.
8. The glass-based particles intermixed into a carrier of claim 6 wherein the one or more trace elements comprise Cu in a concentration which is between 0.1 and 2.5 wt %.
9. The glass-based particles intermixed into a carrier of claim 6 wherein the one or more trace elements comprise 0.05 to 5 wt % Zn.
10. The glass-based particles intermixed into a carrier of claim 5 wherein the glass-based particles comprise from about 50 to about 80 wt % B 2 O 3 , 1 to 25 wt % Na 2 O, 1 to 25% K 2 O, 1 to 40 wt % CaO, 1 to 25 wt % MgO, and 1 to 10 wt % P 2 O 5 .
11. The glass-based particles intermixed into a carrier of claim 6 wherein the glass-based particles comprise from about 50 to about 80 wt % B 2 O 3 , 1 to 25 wt % Li 2 O, and 1 to 40 wt % CaO.
12. The glass-based particles intermixed into a carrier of claim 6 wherein the glass-based particles comprise from about 50 to about 80 wt % B 2 O 3 , 1 to 25 wt % Na 2 O, and 1 to 40 wt % CaO.
13. The glass-based particles intermixed into a carrier of claim 6 wherein the glass-based particles comprise from about 50 to about 80 wt % B 2 O 3 , 1 to 25 wt % Na 2 O, and 1 to 40 wt % BaO.
14. The glass-based particles intermixed into a carrier of claim 6 wherein any Ca concentration in the glass-based particles is strictly controlled to less than 0.5 wt %.
15. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles consist essentially of the B 2 O 3 from 40 to about 80 wt %; two or more alkali oxides selected from the group consisting of Li 2 O, Na 2 O, K 2 O, and Rb 2 O; and two or more alkaline earth oxides from the group consisting of MgO, SrO, BaO, and CaO; plus Cu as the trace element in the concentration between about 0.05 and 10 wt %.
16. The glass-based particles intermixed into a carrier of claim 1 wherein the carrier is the surgical glue.
17. The glass-based particles intermixed into a carrier of claim 1 wherein the particles have a particle size between about 1 and about 300 μm.
18. The glass-based particles intermixed into a carrier of claim 1 wherein the particles comprise microspheres.
19. The glass-based particles of the biocompatible material intermixed into the carrier for angiogenesis in wound-care management of claim 1 , wherein the glass-based particles comprise no silica (SiO 2 ).
20. The glass-based particles of the biocompatible material intermixed into the carrier for angiogenesis in wound-care management of claim 1 , wherein the glass-based particles comprise less than 0.1 wt % silica (SiO 2 ).
21. The glass-based particles of the biocompatible material intermixed into the carrier for angiogenesis in wound-care management of claim 1 , wherein the glass-based particles comprise silica (SiO 2 ) in a concentration of up to 18 wt %.
22. The glass-based particles intermixed into a carrier of claim 5 wherein the carrier is the biocompatible ointment.
23. The glass-based particles intermixed into a carrier of claim 5 wherein the carrier is the biocompatible cream.